Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GX-19N Booster in Healthy Individuals
NCT05067946Phase 3Withdrawn
- Sponsor
- Genexine
- Start
- Oct 2021
- Primary completion
- Oct 2022
- Modality
- Prophylactic Vaccines, DNA Vaccines
01
Overview
A Phase 3 trial of GX-19N in coronavirus disease 2019 (COVID-19), sponsored by Genexine. Planned start Oct 2021; status: withdrawn.
02
Drugs
GX-19N
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05067946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05067946.